Literature DB >> 18955169

Interaction between the N-terminal SH3 domain of Nck-alpha and CD3-epsilon-derived peptides: non-canonical and canonical recognition motifs.

Clara M Santiveri1, Aldo Borroto, Luis Simón, Manuel Rico, Balbino Alarcón, M Angeles Jiménez.   

Abstract

The first SH3 domain (SH3.1) of Nckalpha specifically recognizes the proline-rich region of CD3varepsilon, a subunit of the T cell receptor complex. We have solved the NMR structure of Nckalpha SH3.1 that shows the characteristic SH3 fold consisting of two antiparallel beta-sheets tightly packed against each other. According to chemical shift mapping analysis, a peptide encompassing residues 150-166 of CD3varepsilon binds at the canonical SH3 binding site. An exhaustive comparison with the structures of other SH3 domains able and unable to bind CD3varepsilon reveals that Nckalpha SH3.1 recognises a non-canonical PxxPxxDY motif that orientates at the binding site as a class II ligand. A positively charged residue (K/R) at position -2 relative to the WW sequence at the beginning of strand beta3 is crucial for PxxDY recognition. A 14-mer optimised Nckalpha SH3.1 ligand was found using a multi-substitution approach. Based on NMR data, this improved ligand binds Nckalpha SH3.1 through a PxxPxRDY motif that combines specific stabilising interactions corresponding to both canonical class II, PxxPx(K/R), and non-canonical PxxPxxDY motifs. This explains its higher capacity for Nckalpha SH3.1 binding relative to the wild type sequence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955169     DOI: 10.1016/j.bbapap.2008.09.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Autoinhibitory interaction in the multidomain adaptor protein Nck: possible roles in improving specificity and functional diversity.

Authors:  Koh Takeuchi; Zhen-Yu J Sun; Sunghyouk Park; Gerhard Wagner
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

2.  Nck recruitment to the TCR required for ZAP70 activation during thymic development.

Authors:  Aldo Borroto; Irene Arellano; Elaine P Dopfer; Marek Prouza; Miloslav Suchànek; Manuel Fuentes; Alberto Orfao; Wolfgang W Schamel; Balbino Alarcón
Journal:  J Immunol       Date:  2012-12-24       Impact factor: 5.422

3.  Small molecule AX-024 reduces T cell proliferation independently of CD3ϵ/Nck1 interaction, which is governed by a domain swap in the Nck1-SH3.1 domain.

Authors:  Kirsten Richter; Arne C Rufer; Magali Muller; Dominique Burger; Fabio Casagrande; Tabea Grossenbacher; Sylwia Huber; Melanie N Hug; Philipp Koldewey; Andrea D'Osualdo; Daniel Schlatter; Theodor Stoll; Markus G Rudolph
Journal:  J Biol Chem       Date:  2020-04-21       Impact factor: 5.157

4.  New Label-Free Biosensing for the Evaluation of the AX-024 Inhibitor: Case Study for the Development of New Drugs in Autoimmune Diseases.

Authors:  Yolanda Ramírez; María Fe Laguna; Miguel Holgado
Journal:  Sensors (Basel)       Date:  2022-02-05       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.